Latest Breaking News On - Pharmaceuticals trading down - Page 14 : comparemela.com

Avadel Pharmaceuticals (NASDAQ:AVDL) Shares Gap Down to $18 18

Avadel Pharmaceuticals (NASDAQ:AVDL) Shares Gap Down to $18 18
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesCraig hallumPiper sandlerAvadel pharmaceuticals trading downAvadel pharmaceuticals company profileDeutsche bankVivo capitalNews ratings for avadel pharmaceuticals dailyInstitutional investors weigh in on avadel pharmaceuticalsAvadel pharmaceuticalsGet free reportPharmaceuticals trading downInvestment partnersFlamel technologiesAvadel pharmaceuticals daily

Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target Cut to $382 00 by Analysts at Citigroup

Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target Cut to $382 00 by Analysts at Citigroup
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesRichards levyRebecca taubMadrigal pharmaceuticals incCanaccord genuity groupMontaga associates incAnalyst recommendations for madrigal pharmaceuticalsMadrigal pharmaceuticalsNews ratings for madrigal pharmaceuticals dailyGlobal retirement partnersSecurities exchange commissionInsider transactions at madrigal pharmaceuticalsMadrigal pharmaceuticals trading downChina universal asset management coGet free reportPharmaceuticals trading down

Needham & Company LLC Reaffirms Buy Rating for Rocket Pharmaceuticals (NASDAQ:RCKT)

Needham & Company LLC Reaffirms Buy Rating for Rocket Pharmaceuticals (NASDAQ:RCKT)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Davidp southwellZurcher kantonalbank zurich cantonalbankHedge funds weigh in on rocket pharmaceuticalsCantor fitzgeraldAllspring global investments holdingsMirae asset global investments coNews ratings for rocket pharmaceuticals dailyAnalyst recommendations for rocket pharmaceuticalsTd asset management incJpmorgan chase coRocket pharmaceuticals trading downInsider transactions at rocket pharmaceuticalsRocket pharmaceuticalsNeedham companyGoldman sachs groupRocket pharmaceuticals inc

Oppenheimer Reiterates Market Perform Rating for ACADIA Pharmaceuticals (NASDAQ:ACAD)

Oppenheimer reiterated their market perform rating on shares of ACADIA Pharmaceuticals (NASDAQ:ACAD – Free Report) in a report published on Monday morning, Benzinga reports. They currently have a $19.00 target price on the biopharmaceutical company’s stock. ACAD has been the topic of a number of other research reports. JPMorgan Chase & Co. decreased their price […]

United statesRobertw bairdBrendan teehanStephen davisQuest partnersPharmaceuticals dailyPharmaceuticals trading downRoyal bankSecurities exchange commissionLegato capital managementChina universal asset management coPharmaceuticals incJpmorgan chase coAcadian asset managementPharmaceuticals company profileFree report

Rocket Pharmaceuticals (NASDAQ:RCKT) Announces Quarterly Earnings Results

Rocket Pharmaceuticals (NASDAQ:RCKT) Announces Quarterly Earnings Results
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Kinnari patelGaurav shahRocket pharmaceuticals trading downEarnings history for rocket pharmaceuticalsNeedham companySecurities exchange commissionRocket pharmaceuticalsGoldman sachs groupJpmorgan chase coNews ratings for rocket pharmaceuticals dailyRocket pharmaceuticals incGet free reportPharmaceuticals trading downExchange commissionRocket pharmaceuticals daily